Guo, Jing and Yang, Wei-Lei and Pak, Daewoo and Celestino, Joseph and Lu, Karen H. and Ning, Jing and Lokshin, Anna E. and Cheng, Zhongping and Lu, Zhen and Bast, Robert C.
(2019)
Osteopontin, Macrophage Migration Inhibitory Factor and Anti-Interleukin-8 Autoantibodies Complement CA125 for Detection of Early Stage Ovarian Cancer.
Cancers, 11 (5).
p. 596.
ISSN 2072-6694
Abstract
Early detection of ovarian cancer promises to reduce mortality. While serum CA125 can detect more than 60% of patients with early stage (I–II) disease, greater sensitivity might be observed with a panel of biomarkers. Ten protein antigens and 12 autoantibody biomarkers were measured in sera from 76 patients with early stage (I–II), 44 patients with late stage (III–IV) ovarian cancer and 200 healthy participants in the normal risk ovarian cancer screening study. A four-biomarker panel (CA125, osteopontin (OPN), macrophage inhibitory factor (MIF), and anti-IL-8 autoantibodies) detected 82% of early stage cancers compared to 65% with CA125 alone. In early stage subjects the area under the receiver operating characteristic curve (AUC) for the panel (0.985) was significantly greater (p < 0.001) than the AUC for CA125 alone (0.885). Assaying an independent validation set of sera from 71 early stage ovarian cancer patients, 45 late stage patients and 131 healthy women, AUC in early stage disease was improved from 0.947 with CA125 alone to 0.974 with the four-biomarker panel (p = 0.015). Consequently, OPN, MIF and IL-8 autoantibodies can be used in combination with CA125 to distinguish ovarian cancer patients from healthy controls with high sensitivity. Osteopontin appears to be a robust biomarker that deserves further evaluation in combination with CA125
Share
| Citation/Export: |
|
| Social Networking: |
|
Details
| Item Type: |
Article
|
| Status: |
Published |
| Creators/Authors: |
| Creators | Email | Pitt Username | ORCID  |
|---|
| Guo, Jing | | | | | Yang, Wei-Lei | | | | | Pak, Daewoo | | | | | Celestino, Joseph | | | | | Lu, Karen H. | | | | | Ning, Jing | | | | | Lokshin, Anna E. | loksax@upmc.edu | | | | Cheng, Zhongping | | | | | Lu, Zhen | | | | | Bast, Robert C. | | | |
|
| Date: |
28 April 2019 |
| Date Type: |
Publication |
| Journal or Publication Title: |
Cancers |
| Volume: |
11 |
| Number: |
5 |
| Publisher: |
MDPI AG |
| Page Range: |
p. 596 |
| DOI or Unique Handle: |
10.3390/cancers11050596 |
| Schools and Programs: |
School of Medicine > Pathology |
| Refereed: |
Yes |
| Uncontrolled Keywords: |
ovarian cancer, osteopontin (OPN), macrophage migration inhibitory factor (MIF), CA125, IL-8 autoantibodies (IL-8 AAb), early detection |
| ISSN: |
2072-6694 |
| Official URL: |
http://dx.doi.org/10.3390/cancers11050596 |
| Funders: |
National Cancer Institute Early Detection Research Network, MD Anderson Ovarian SPOREs, National Cancer Institute, Department of Health and Human Services, Cancer Prevention Research Institute of Texas, Minnesota Ovarian Cancer Alliance, Golfer’s Against Cancer, Mossy Foundation, Roberson Endowment, National Foundation for Cancer Research, UT MD Anderson Women’s Moon Shot, Stuart and Gaye Lynn Zarrow |
| Article Type: |
Research Article |
| Date Deposited: |
11 Jun 2021 20:39 |
| Last Modified: |
11 Jun 2021 20:39 |
| URI: |
http://d-scholarship.pitt.edu/id/eprint/41273 |
Metrics
Monthly Views for the past 3 years
Plum Analytics
Altmetric.com
Actions (login required)
 |
View Item |
![[feed]](/images/feed-icon-32x32.png){kind=icon}